Jul 16, 2026 09:00AM
Jun 30, 2026 09:17AM
May 6, 2026 05:07PM
Apr 27, 2026 08:01AM
Apr 22, 2026 08:04AM
Mar 10, 2026 09:00AM
Mar 2, 2026 06:39AM Arcutis Biotherapeutics Inc. (ARQT) PT Lowered to $35 at Mizuho
Feb 26, 2026 07:14AM
Feb 26, 2026 06:40AM
Feb 25, 2026 04:04PM
Jan 26, 2026 08:00AM
Jan 12, 2026 08:10AM
Dec 21, 2025 08:00PM
Dec 8, 2025 04:03PM Arcutis appoints Amit Munshi to board, founder Bhaskar Chaudhuri retires
Nov 28, 2025 06:33AM
Nov 17, 2025 08:04AM
Nov 4, 2025 08:04AM
Oct 30, 2025 08:03AM
Oct 29, 2025 06:49AM
Oct 29, 2025 06:11AM
Oct 28, 2025 04:19PM Arcutis Biotherapeutics, Inc. (ARQT) Tops Q3 EPS by 15c
Oct 28, 2025 08:34AM
Oct 24, 2025 08:00AM
Oct 7, 2025 04:02AM
Sep 3, 2025 11:44AM
Aug 6, 2025 04:14PM
Jul 21, 2025 07:05AM
Jul 3, 2025 09:29AM Morgan Stanley Assumes Arcutis Biotherapeutics Inc. (ARQT) at Overweight, PT $20
Jun 9, 2025 06:40AM
Jun 3, 2025 06:55AM
May 22, 2025 02:16PM
May 7, 2025 11:19AM
May 7, 2025 05:09AM
May 6, 2025 04:55PM
Apr 10, 2025 04:31PM Arcutis Biotherapeutics (ARQT) appoints Latha Vairavan as CFO after Topper retirement
Apr 3, 2025 06:49AM
Apr 2, 2025 01:18PM
Mar 11, 2025 02:19PM
Feb 26, 2025 08:02AM
Feb 26, 2025 05:28AM
Feb 25, 2025 04:40PM
Feb 24, 2025 08:00AM Arcutis Biotherapeutics (ARQT) Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE® (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with Mild to Moderate Atopic
Jan 13, 2025 07:17AM
Jan 6, 2025 04:32PM
Dec 30, 2024 06:32AM
Dec 16, 2024 08:06AM
Dec 3, 2024 08:05AM
Nov 26, 2024 02:22PM
Nov 6, 2024 04:14PM Arcutis Biotherapeutics, Inc. (ARQT) Tops Q3 EPS by 9c
Oct 18, 2024 08:21AM

430,619 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All